0 likes | 13 Views
The global Methylphenidate market is projected to experience significant growth during the forecast period (2024-2030). Methylphenidate, a central nervous system stimulant, is primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD). The increasing prevalence of ADHD, coupled with rising awareness about the disorder and its effective treatment options, is driving market demand. Additionally, the growing geriatric population and the increasing incidence of ADHD in adults are further fueling market expansion.
E N D